Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000145003 | SCV000303813 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000364373 | SCV000369218 | benign | Permanent neonatal diabetes mellitus | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000389101 | SCV000369219 | benign | Hyperinsulinism, Dominant/Recessive | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000293707 | SCV000369220 | benign | Transient Neonatal Diabetes, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001094008 | SCV000483252 | benign | Diabetes mellitus, transient neonatal, 2 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000348648 | SCV000483253 | likely benign | Maturity onset diabetes mellitus in young | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001094009 | SCV000483254 | likely benign | Hyperinsulinemic hypoglycemia, familial, 1 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Labcorp Genetics |
RCV001521375 | SCV001730710 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Pars Genome Lab | RCV001533238 | SCV001749039 | benign | Leucine-induced hypoglycemia | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Pars Genome Lab | RCV001094009 | SCV001749040 | benign | Hyperinsulinemic hypoglycemia, familial, 1 | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Pars Genome Lab | RCV001094008 | SCV001749041 | benign | Diabetes mellitus, transient neonatal, 2 | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Pars Genome Lab | RCV001533239 | SCV001749042 | benign | Diabetes mellitus, permanent neonatal 3 | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001521375 | SCV001939727 | benign | not provided | 2018-10-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001521375 | SCV002048321 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002226683 | SCV002505641 | uncertain significance | Neonatal hypoglycemia | criteria provided, single submitter | research | Mutations in the ABCC8 gene are associated with both neonatal diabetes mellitus as well as MODY. Patients with this mutation have a better response to sulfonylureas. However, the significance of rs8192690 in neonatal Diabetes Mellitus is uncertain. | |
Genetic Services Laboratory, |
RCV000145003 | SCV000192039 | benign | not specified | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001826797 | SCV002085237 | benign | Hereditary hyperinsulinism | 2019-11-22 | no assertion criteria provided | clinical testing |